{"id":"https://genegraph.clinicalgenome.org/r/3c875f40-edee-45d2-bc38-5199c057bbccv1.0","type":"EvidenceStrengthAssertion","dc:description":"RNF43 was first reported in relation to autosomal dominant sessile serrated polyposis (SPS) cancer syndrome in 2014 (Gala et al., PMID: 24512911). SPS is a rare, genetic intestinal disease characterized by the presence of multiple (usually large) serrated colorectal polyps, associated with an increased personal and familial risk of colorectal cancer. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found only one disease entity associated with this gene [Sessile serrated polyposis cancer syndrome] (OMIM:617108). Seven variants (missense, nonsense, frameshift, splice site) that have been reported in nine probands in seven publications (PMIDs: 27081527, 27329244, 27582512, 29330307, 35128723, 34541672, 34761457) are included in this curation (10.7 points). The mechanism of pathogenicity is reported to be heterozygous LOF. This gene-disease relationship is also supported by experimental evidence (3.6 points from animal model, expression studies, in vitro functional assays and second hits in patients' cells) (PMIDs: 18313049, 22895187, 26350900, 27329244, 32934222). Experimental evidence shows that RNF43 is an E3 ubiquitin ligase that negatively regulates Wnt signaling by inducing degradation of the Wnt receptor Frizzled, impacting intestinal cell proliferation. In summary, there is definitive evidence to support the relationship between RNF43 and autosomal dominant sessile serrated polyposis cancer syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3c875f40-edee-45d2-bc38-5199c057bbcc","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-12-30T18:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-12-30T21:52:32.268Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8756a8ca-0a72-4feb-8836-e43fdb4d23ce","type":"EvidenceLine","dc:description":"Single RNF43 cKO homozygous mutants did not yield any discernible phenotype. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f55cea6-5e6e-4421-a4a8-f0a45aa0ab94","type":"Finding","dc:description":"RNF43/ZNRF3 conditional knockout mice develop intestinal metaplasia  and multiple adenomas. Histology of adenomas is not described.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22895187","rdfs:label":"RNF43/ZNRF3 conditional knockout mice with Vil-creERT2","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7d890cdb-257a-4adb-a939-ce28169941ba","type":"EvidenceLine","dc:description":"Reduced since not related to serrated polyps.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f37b40ea-3fc9-4734-ab21-8a8c21a48608","type":"Finding","dc:description":"Expression of RNF43(3SD) during short-term culture of organoids in the ENR condition significantly suppressed organoid growth. \nExpression of RNF43(3SA) improved their viability. These results suggest that phospho-regulation of RNF43 is required for the survival and the growth of crypts, and that this regulation occurs independently of the RNF43-Rspo-Lgr regulatory module.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32934222","rdfs:label":"RNF43 mutants impact in intestinal organoid growth","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0d9dd15-6beb-4446-9d54-8aa731711947","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b83e8c5e-7960-4714-ad28-a3a2180f021c","type":"FunctionalAlteration","dc:description":"Second somatic hits (LOH or LOF somatic mutations) in polyps or CRC from  family members carriers of RNF43 LOF germline variant.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27329244","rdfs:label":"Second hits"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1d65dffb-2083-4eff-95e8-1a93578b4459","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fbdf4893-7de6-451f-9952-f93430380e23","type":"FunctionalAlteration","dc:description":"Abolished the inhibitory effect on Wnt signaling but also enhanced Wnt signaling activity in a dose-dependent manner","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26350900","rdfs:label":"Inactivation of the RING domain "}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9daaea76-2d19-4baf-82ff-b84052a98de2","type":"EvidenceLine","dc:description":"Scored at Koo et al. 2012. \n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b3afd64-9010-4ee1-a33e-74630a7ad499","type":"FunctionalAlteration","dc:description":"Knocking down RNF43 in the colon cancer cell line HT-29  significantly increased TCF transcriptional activity, confirming that RNF43 is an endogenous repressor of Wnt activity.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26350900","rdfs:label":"Knockdown in colon cell lines"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/54e3b929-089a-4cde-b78a-8639655c45a0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc151d66-4ceb-4e98-9663-6f612580f0ef","type":"FunctionalAlteration","dc:description":"RNF43 knockdown increases TCF4-β-catenin activity measured by luciferase assay and promotes ubiquitin-mediated endocytosis of frizzled receptors \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22895187","rdfs:label":"Wnt reporter assays"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ee1f27a-2c0e-4658-bfb7-ca7fa90917ad","type":"EvidenceLine","dc:description":"More expressed in adenoma and CRC than normal colon – contradiction with LOF mechanism?","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3df88032-ef83-4084-b367-45e8a709dccc","type":"Finding","dc:description":"BioExpress\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18313049","rdfs:label":"Expression analysis in array data","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7ab9ae71-57d5-4f4e-a8f5-dbc38395ce54","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bf780cd-ff8f-4081-945c-ae8b641dec09","type":"Finding","dc:description":"Expressed specifically in LGR5+ stem cells in the intestinal crypts.\nGTEx","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22895187","rdfs:label":"Microarray expression profiling and in situ hybridization ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.6},{"id":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85ee130e-2d5b-4b51-8175-c6fbc1998a1c","type":"EvidenceLine","dc:description":"Gnomad: 0.0000439 / higher MAF 0.000163\nClinvar: VUS\nRevel: 0.17\n\n ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85ee130e-2d5b-4b51-8175-c6fbc1998a1c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27582512","allele":{"id":"https://genegraph.clinicalgenome.org/r/77b06833-e1fe-4ca2-b881-8c5291700765","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017763.6(RNF43):c.443C>G (p.Ala148Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1426271"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6afee093-869f-471f-aa8b-842351262c9f","type":"EvidenceLine","dc:description":"Gnomad: Not described ; Clinvar: P – 1 submitter","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6afee093-869f-471f-aa8b-842351262c9f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27081527","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d938830-f46b-4e77-84cb-7793730befea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017763.6(RNF43):c.394C>T (p.Arg132Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA214568"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3245cd72-8f10-48ee-9861-104f851adb0f","type":"EvidenceLine","dc:description":"Gnomad: Not Described; Clinvar: VUS – 1 submitter","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3245cd72-8f10-48ee-9861-104f851adb0f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24512911","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8026102-b9f8-46ff-8a68-4e2206fb0e29","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017763.6(RNF43):c.337C>T (p.Arg113Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254140"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/66ea7fb4-6795-492a-824f-9c5602e6106b","type":"EvidenceLine","dc:description":"Gnomad: Not described; Clinvar: P – 1 submitter\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66ea7fb4-6795-492a-824f-9c5602e6106b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29330307","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d938830-f46b-4e77-84cb-7793730befea"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5efcaaad-5ec4-4b29-b664-659d66c0f781","type":"EvidenceLine","dc:description":"Gnomad: Not Described; Clinvar: VUS – 1 submitter","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5efcaaad-5ec4-4b29-b664-659d66c0f781_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24512911","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8026102-b9f8-46ff-8a68-4e2206fb0e29"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f6d7ce34-c6fb-4e32-baae-d7466d849e18","type":"EvidenceLine","dc:description":"Gnomad: 0.000112 / higher MAF 0.000329\nClinvar: VUS \nRevel: 0.1369\n\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6d7ce34-c6fb-4e32-baae-d7466d849e18_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27582512","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a6be49a-5058-46ea-adb2-5574a2505b76","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017763.6(RNF43):c.640C>G (p.Leu214Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/859220"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/279d6366-26ca-4151-bc19-a9bb3014f8e1","type":"EvidenceLine","dc:description":"Gnomad: 0.00000657\nClinvar: VUS – 1 submitter\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/279d6366-26ca-4151-bc19-a9bb3014f8e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35128723","allele":{"id":"https://genegraph.clinicalgenome.org/r/8cbf0680-79db-4a37-8984-1f9b2eda3ef5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_017763.6(RNF43):c.471del (p.Thr158fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1044671"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c8e5a98-59c1-4b1d-8b7c-db16713b7a8d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27081527","rdfs:label":"Taupin F01","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/5c8e5a98-59c1-4b1d-8b7c-db16713b7a8d","type":"Family","rdfs:label":"Taupin F01","member":{"id":"https://genegraph.clinicalgenome.org/r/357adabc-2fc4-4771-9575-b27cc58ca323","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27081527","rdfs:label":"II.2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":23,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8d938830-f46b-4e77-84cb-7793730befea"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":">50 sessil serrated adenomas","phenotypes":["obo:HP_0032222","obo:HP_0003003"],"previousTesting":true,"previousTestingDescription":"Sequencing of the MUTYH gene in the germline was normal","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6afee093-869f-471f-aa8b-842351262c9f_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0032222","proband":{"id":"https://genegraph.clinicalgenome.org/r/357adabc-2fc4-4771-9575-b27cc58ca323"}},{"id":"https://genegraph.clinicalgenome.org/r/01667d26-31c7-46c6-a0c7-adbff374ee39_proband_segregation","type":"FamilyCosegregation","dc:description":"Exome in proband, candidate variant in relatives.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27329244","rdfs:label":"family A","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/01667d26-31c7-46c6-a0c7-adbff374ee39","type":"Family","rdfs:label":"family A","member":{"id":"https://genegraph.clinicalgenome.org/r/d6b0764e-77a4-47cc-ad04-76920b3b2a4d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27329244","rdfs:label":"A:II-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":65,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d8ac7d81-583d-4d85-8cc1-ed064d0e455b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000017.11:g.58358824C>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400332553"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":">100 sessil serrated adenomas","phenotypes":"obo:HP_0032222","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/83bffa36-6896-42a4-b00a-76ba3dfa81cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27329244","allele":{"id":"https://genegraph.clinicalgenome.org/r/d8ac7d81-583d-4d85-8cc1-ed064d0e455b"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":"obo:HP_0032222","proband":{"id":"https://genegraph.clinicalgenome.org/r/d6b0764e-77a4-47cc-ad04-76920b3b2a4d"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b240f2e9-934a-472a-b1ad-f38228a3f0c6","type":"EvidenceLine","dc:description":"Sequencing of cDNA identified a single transcript predicted to encode RNF43:p. Ala126Ilefs*50 (Figure 3, Figures S1–S3). ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b240f2e9-934a-472a-b1ad-f38228a3f0c6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Sequencing of cDNA identified a single transcript predicted to encode RNF43:p. Ala126Ilefs*50 (Figure 3, Figures S1–S3). ","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/b240f2e9-934a-472a-b1ad-f38228a3f0c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34761457","allele":{"id":"https://genegraph.clinicalgenome.org/r/627542e5-5edb-478b-b7a6-4dcc4df5d2c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000017.11:g.58370910C>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400343001"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/83bffa36-6896-42a4-b00a-76ba3dfa81cd","type":"EvidenceLine","dc:description":"Gnomad: Not described; Clinvar: Not described","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83bffa36-6896-42a4-b00a-76ba3dfa81cd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Confirmed to cause aberrant splicing and a 2 bp deletion in the RNA (c.953_954delAG), thereby resulting in a truncated protein product (E318fs) (supplementary figure S1). ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/83bffa36-6896-42a4-b00a-76ba3dfa81cd_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10.7}],"evidenceStrength":"Definitive","sequence":5605,"specifiedBy":"GeneValidityCriteria9","strengthScore":14.3,"subject":{"id":"https://genegraph.clinicalgenome.org/r/pY02lrDXN9c","type":"GeneValidityProposition","disease":"obo:MONDO_0014919","gene":"hgnc:18505","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9abf2a1d-21a7-4ef7-99c7-b0b37d5acf38-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}